A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk
KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ — GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix (MAL24056002ARZ), also known as Recombinant Zoster Vaccine, Adjuvanted (RZV) in Malaysia for the prevention of…